Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain

• Status: Terminated
• Trial end date: 2013-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to elucidate whether the additional mechanism of analgesia, i.e. reuptake inhibition of norepinephrine, of tapentadol leads to a change in different pain signs and symptoms in comparison to oxycodone.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital Schleswig-Holstein; University of Schleswig-Holstein
• Treatments: Oxycodone; Tapentadol

Criteria

Inclusion Criteria:

• thermal or mechanical hyperalgesia

• chronic neuropathic pain (NRS => 6)

Exclusion Criteria:

• non-specific